-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
LogicBio Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2017 to Q3 2022.
- LogicBio Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$5.74M, a 42.2% increase year-over-year.
- LogicBio Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$25.9M, a 29.3% increase year-over-year.
- LogicBio Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$39M, a 23.7% decline from 2020.
- LogicBio Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$31.5M, a 23.2% increase from 2019.
- LogicBio Therapeutics, Inc. annual Operating Income (Loss) for 2019 was -$41M, a 129% decline from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)